NCT00672646View on ClinicalTrials.gov

Study to Investigate the Analgesic Efficacy of a Single Dose of AZD1386

PHASE2CompletedINTERVENTIONAL
Enrollment

103

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Pain
Interventions
DRUG

AZD1386

95mg, oral solution, single dose

DRUG

Naproxen

500mg, capsule, single dose

DRUG

Placebo

AZD1386 Placebo oral solution

Trial Locations (1)

Unknown

Research Site, Salt Lake City

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY